Zidovudine (ZDV or AZT)
Pharmaceutical forms
Injection
Country lists
ATC N/A
Composition 10 mg/mL
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Colombia
2.0 AIDS
  • No observations
Cuba
6.4 Antivirales
  • No observations
Oral liquid
Country lists
ATC N/A
Composition 10 mg/mL
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Colombia
2.0 AIDS
  • No observations
Tablet
Country lists
ATC N/A
Composition 100 mg
Observations for this pharmaceutical form can be found on the lists:
Peru
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors
  • No observations
Capsule
Country lists
ATC N/A
Composition 100 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • No observations
Bolivia
LINAME 2011 - 2013
  • No observations
Ecuador
Essential Medicines List - Ecuador
  • No observations
Colombia
2.0 AIDS
  • No observations
Cuba
6.4 Antivirales
  • No observations
Capsule
Country lists
ATC N/A
Composition 250 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
Oral liquid
Country lists
ATC N/A
Composition 50 mg/5 mL
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • No observations
Peru
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors
  • No observations
Solution for IV infusion injection
Country lists
ATC N/A
Composition 10 mg/mL in 20-mL vial
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Chile
Essential and Prioritized Medications
  • No observations
Tablet
Country lists
ATC N/A
Composition 300 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • No observations
Bolivia
LINAME 2011 - 2013
  • No observations
Peru
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors
  • No observations
Chile
Essential and Prioritized Medications
  • No observations
Colombia
2.0 AIDS
  • No observations
Cuba
6.4 Antivirales
  • No observations